Top news of the week: 20.07.2022.
Press Release: Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis
Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis First and only investigational Phase 3 trial to show …
Understanding the Complexities of Monoclonal Antibody Development and Manufacturing
The demand for COVID-19 medicines, like monoclonal antibodies, has caused a ripple effect through global healthcare systems. Read more on the impact.
Ultragenyx Buys GeneTx to Take Angelman ASO the Distance
The buyout comes on the heels of promising Phase I/II results from GTX-102, an antisense oligonucleotide candidate being developed to treat Angelman syndrome.
Who is Nestlé Health Science and How Do They Play in Biopharma?
In the latest in Nestlé's efforts to establish a presence in the gastroenterology space, the company will pay over $40 million upfront to Enterome as part of a new partnership.
Biotech employees cash in health care’s largest salaries, while people working at providers sit near the bottom
It pays to be in the lab. It pays way less to be at the patient’s bedside, according to a STAT analysis of the median pay for employees at more than 200 publicly traded health care ...
GSK consumer health spin-off Haleon starts trading
GSK’s consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with
GenScript 2nd Annual Gene and Cell Engineering Summit
GenScript is delighted to announce its 2nd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, ...
Beyond Biotech podcast 5: ANeuroTech, ISA Pharmaceuticals, Life Length
This week’s guests are Erik Buntinx, ANeuroTech; Stephen J. Matlin, Life Length; and Kees Melief, ISA Pharmaceuticals.